Rank |
Title |
Year |
PubWeight™‹?› |
1
|
Detection of primary HIV infection by a second-generation HIV(p24) antigen test.
|
1994
|
1.59
|
2
|
Isovolemic hemodilution alters the ratio of whole-body to large-vessel hematocrit (F-cell ratio). A prospective, randomized study comparing the volume effects of hydroxyethyl starch 200,000/0.62 and albumin.
|
1995
|
1.46
|
3
|
Frequencies of the blood groups ABO, Rhesus, D category VI, Kell, and of clinically relevant high-frequency antigens in south-western Germany.
|
1995
|
1.46
|
4
|
Modulation of pulmonary vascular resistance and edema formation by short-term infusion of a 10% fish oil emulsion.
|
1993
|
1.43
|
5
|
Blood volume determination with sodium fluorescein and radioactive chromium--a clinical comparison of methods.
|
1994
|
1.43
|
6
|
[18 months experience with a new single needle cytapheresis system (Fresenius AS 104 SN)].
|
1994
|
1.42
|
7
|
[Effect of colloidal plasma substitutes on liberation of tumor necrosis factor-alpha (TNF-alpha) in human whole blood in vitro].
|
1995
|
1.41
|
8
|
[Alanine aminotransferase (ALAT, GPT): a reevaluation of exclusion limits for blood donors].
|
1995
|
1.41
|
9
|
[Effectiveness of preventing hypotension with H1/H2 antagonists before protamine administration].
|
1994
|
1.40
|
10
|
[Glutamine supplemented nutrition in clinical practice--use of glutamine-containing dipeptides].
|
1995
|
1.39
|
11
|
[Severe dextran-induced anaphylactic/anaphylactoid reaction despite preventive hapten administration].
|
1993
|
1.39
|
12
|
Atrial natriuretic peptide (ANP), aldosterone, angiotensin II and renin in the 'low T3 syndrome' in organ donors.
|
1992
|
1.39
|
13
|
[Post-aggression metabolism: attempt at a status determination].
|
1994
|
1.39
|
14
|
How accurate is serologic testing of plasma pools for hepatitis B virus surface antigen, anti-human immunodeficiency virus 1 and 2, and anti-hepatitis C virus?
|
1996
|
1.39
|
15
|
[Measurement errors in determination of electrolyte concentrations with ion selective electrodes in the presence of inorganic or metabolizable anions].
|
1992
|
1.39
|
16
|
Amino acid-enriched glucose-insulin-potassium infusion improves hemodynamic function after coronary bypass surgery. A double-blind study in patients with unstable angina and/or compromised left ventricular function.
|
1995
|
1.37
|
17
|
[Degree of patient education retardation preoperative autologous blood donation at a university clinic].
|
1996
|
1.37
|
18
|
[A retrospective study of the practice of "look-back" procedures, on the incidence of HIV-1/2-positive blood donors and the risk of transfusion-associated HIV infection in public-community blood banks in Germany].
|
1994
|
1.08
|
19
|
[Cryopreservation of human erythrocytes with hydroxyethyl starch (HES)--Part 2: Analysis of survival].
|
1992
|
1.07
|
20
|
[Cryopreservation of human erythrocytes with hydroxyethyl starch (HES)--Part 1: The procedure].
|
1992
|
1.07
|
21
|
[HIV retrospective study of the German Red Cross blood donation service in Germany].
|
1994
|
1.07
|
22
|
Screening of blood donors and recipients for Borrelia burgdorferi antibodies: no evidence of B. burgdorferi infection transmitted by transfusion.
|
1992
|
0.99
|
23
|
[Possibilities and limits of anti-HCV antibody screening in the blood donation service].
|
1994
|
0.91
|
24
|
[High-dose immunoglobulin therapy of hyperbilirubinemia in rhesus incompatibility].
|
1993
|
0.86
|
25
|
[The elimination of carboxyhemoglobin--gender-specific and circadian effects].
|
1992
|
0.85
|
26
|
[Antibody induction after intrauterine interventions].
|
1993
|
0.83
|
27
|
[Model calculations for HIV screening of blood and plasma donors with a combination of 2 screening tests: test strategies, validity, costs and effectiveness].
|
1995
|
0.83
|
28
|
[Use of plasmapheresis in a 62-year-old patient with severe infection].
|
1996
|
0.83
|
29
|
[Survey of blood donors on the topic of "reimbursement for blood donors"].
|
1995
|
0.83
|
30
|
Improved cumulated nitrogen balance after administration of recombinant human growth hormone in patients undergoing gastrointestinal surgery.
|
1994
|
0.82
|
31
|
[Compatibility problems in intensive care medicine].
|
1994
|
0.82
|
32
|
[Suitability of monoclonal test sera for determination of blood group markers in positive direct Coombs test].
|
1995
|
0.82
|
33
|
Determination and Successful Transfusion of Anti-Gerbich-Positive Red Blood Cells in a Patient with a Strongly Reactive Anti-Gerbich Antibody.
|
2000
|
0.82
|
34
|
Safety of dextran in relation to other colloids--ten years experience with hapten inhibition.
|
1993
|
0.81
|
35
|
Freezing technique and quality of fresh-frozen plasma.
|
1992
|
0.80
|
36
|
Red cell destruction in cold agglutinin disease.
|
1994
|
0.79
|
37
|
Diagnosis and epidemiology of transfusion-associated human cytomegalovirus infection: recent developments.
|
1994
|
0.79
|
38
|
[Physiology and clinical aspects of the extracellular bicarbonate pool: plea for cognizant use of HCO3-].
|
1993
|
0.79
|
39
|
Perioperative respiratory monitoring of oxygen transport.
|
1993
|
0.78
|
40
|
Transfusion-Associated Infections with Cytomegalovirus and Other Human Herpesviruses.
|
2000
|
0.78
|
41
|
Another function of erythrocytes: transport of circulating immune complexes.
|
1995
|
0.78
|
42
|
Analysis of cytokine profiles of stored CPDA-1 whole blood.
|
1995
|
0.78
|
43
|
[Risk of HIV transmission by blood transfusion].
|
1995
|
0.78
|
44
|
Benefits of early postoperative enteral feeding in cancer patients.
|
1995
|
0.78
|
45
|
Age, sex and transaminase dependency of specific and nonspecific results from enzyme immunoassays for antibodies to hepatitis C virus and follow-up of blood donors.
|
1995
|
0.78
|
46
|
[Current aspects of preoperative autologous blood donation with legal implications].
|
1992
|
0.78
|
47
|
Activation of complement by cold agglutinins.
|
1994
|
0.78
|
48
|
Participation of the blood platelet in immune reactions due to platelet-complement interaction.
|
1995
|
0.78
|
49
|
The role of lipoproteins in the inactivation of endotoxin by serum.
|
1992
|
0.78
|
50
|
Superiority of gel centrifugation in antibody screening and identification.
|
1992
|
0.78
|